Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable…
Overview of attention for article published in Journal of Clinical Oncology, October 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Mentioned by
- news
- 7 news outlets
- blogs
- 1 blog
- 29 X users
- patent
- 3 patents
- 1 Facebook page
- guideline
- 2 clinical guideline sources
Readers on
- mendeley
- 419 Mendeley